Anti-osteoporotic drugs

Anti-osteoporotic drugs has been studied in 6 papers since 2021: 5 observational studies in people, 1 review; 1 in the past year. The newest paper, Nov 12, 2026: “Effects of aerobic, resistance, and combined exercise on postmenopausal women with osteopenia or osteoporosis: a systematic review and network meta-analysis”.

Intervention

6 papers study it3 findingsUpdated

1 new paper in 30 daysSee all 6 papers on anti-osteoporotic drugs

At a glance

The findings reach people, from one lab or study. 2 independent labs in 2 countries.

“Patients who were adherent to AOD after 12 months had a 49% lower risk of subsequent fractures than non-adherent patients (HR 0.51; 95% CI 0.35-0.72)”
Adherence to secondary fracture prevention is associated with reduced risk of subsequent fracturesOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2025doi:10.1007/s00198-025-07697-6

1 of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 2 independent labs in 2 countries
  • 1 finding against
  • Funders: Northern Norway Regional Health Authority and 2 more
  • 3 of 3 findings with company ties
  • Humans5

What did studies of anti-osteoporotic drugs find?

1

Studies of anti-osteoporotic drugs measured one outcome, mortality.

Mortality

no changein humans1downin humans1HR 0.75

2 studies
  1. Anti-osteoporotic drugs were not clearly linked with mortality in humans (index fracture of any type) (no difference).

    Humansindex fracture of any type12 months after treatment initiation

  2. Anti-osteoporotic drugs are linked with lower mortality in humans after hip fracture, treated with anti-osteoporotic drugs (adjusted HR 0.75, 95% CI 0.59-0.96).

    Humansafter hip fracture, treated with anti-osteoporotic drugs1 year

What is anti-osteoporotic drugs linked with?

1

Studies link anti-osteoporotic drugs with subsequent fractures.

Subsequent fractures

downin humans1HR 0.51

1 study
  1. Anti-osteoporotic drugs are linked with a lower risk of subsequent fractures in humans (index fracture of any type) (HR 0.51, 95% CI 0.35-0.72).

    Humansindex fracture of any type12 months after treatment initiation

More on Subsequent fractures

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 11 paper in 12 months